Nowadays, when we go into the pharmacy to buy drugs, we often find a small bag on the outside of the PTP (aluminum plastic blister) package. For most ordinary patients, they usually think that such drug packaging is more sealed, which can better protect the quality of drugs and make them safer and more reliable. However, from the perspective of pharmaceutical manufacturers, this kind of bagging is actually a helpless move.

In the pharmaceutical packaging industry, experts generally believe that adding a bag to PTP packaging drugs seems to increase the safety of drugs, but in fact this approach is neither effective nor economical. From the perspective of drug quality, this additional packaging does not really protect the drug. In addition, this packaging method will increase production costs and operating costs, which is undoubtedly not conducive to the long-term development of enterprises. For ordinary patients, they may not understand the complexity of pharmaceutical packaging and some of the details of the industry.

Therefore, they may be inclined to accept this seemingly safer packaging because of concerns about drug safety. However, in the long run, drug manufacturers should pay more attention to the quality and safety of drugs, and ensure the safety and effectiveness of drugs by improving production processes and improving technical levels. At the same time, companies should also strengthen communication and exchanges with patients, and explain to them the true purpose and reasons behind this packaging method, so as to increase patients' trust and understanding of drugs.

In short, while adding a bag to a PTP-packaged drug may give patients more peace of mind and peace of mind, from an industry perspective, this approach is neither effective nor economical. Therefore, drug manufacturers should pay more attention to the quality and safety of drugs, and ensure the safety and health of patients through more scientific and reasonable packaging methods.